1. (−)-Epigallocatechin Gallate Targets Notch to Attenuate the Inflammatory Response in the Immediate Early Stage in Human Macrophages
    Tengfei Wang et al, 2017, Front. Immunol. CrossRef
  2. Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases
    Qian Yi Eng et al, 2018, Journal of Ethnopharmacology CrossRef
  3. Silencing of H19 inhibits the adipogenesis and inflammation response in ox-LDL-treated Raw264.7 cells by up-regulating miR-130b
    Yong Han et al, 2018, Molecular Immunology CrossRef
  4. Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?
    Ding-Yuan Tian et al, 2017, IJMS CrossRef
  5. (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
    Li-Long Pan et al, 2018, Front. Pharmacol. CrossRef
  6. Natural plant products in treatment of pulmonary arterial hypertension
    Lili Xiang et al, 2018, Pulm Circ CrossRef
  7. Dietary compounds have potential in controlling atherosclerosis by modulating macrophage cholesterol metabolism and inflammation via miRNA
    Dongyan Shao et al, 2018, npj Sci Food CrossRef
  8. null
    Kazuo Yamagata, 2018 CrossRef
  9. Roles of eNOS in atherosclerosis treatment
    Fen-fang Hong et al, 2019, Inflamm. Res. CrossRef
  10. The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway
    Giorgio Aquila et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  11. Effects and Mechanisms of Tea and Its Bioactive Compounds for the Prevention and Treatment of Cardiovascular Diseases: An Updated Review
    Shi-Yu Cao et al, 2019, Antioxidants CrossRef
  12. Knockdown of LSD1 meliorates Ox-LDL-stimulated NLRP3 activation and inflammation by promoting autophagy via SESN2-mesiated PI3K/Akt/mTOR signaling pathway
    Xiaozhen Zhuo et al, 2019, Life Sciences CrossRef
  13. Notch, lipids, and endothelial cells
    Anaïs Briot et al, 2016, Current Opinion in Lipidology CrossRef
  14. Epigallocatechin-3-gallate inhibits H2O2-induced apoptosis in Mouse Vascular Smooth Muscle Cells via 67kD Laminin Receptor
    Xue Yan et al, 2017, Sci Rep CrossRef
  15. EGCG exerts its protective effect by mitigating the release of lysosomal enzymes in aged rat liver on exposure to high cholesterol diet
    Rajeswari Ravindran et al, 2020, Cell Biochem Funct CrossRef
  16. Cardiovascular Effects of Flavonoids
    Manuel Sánchez et al, 2019, CMC CrossRef
  17. Epigallocatechin-3-gallate in functional food development: From concept to reality
    Wing-Fu Lai et al, 2020, Trends in Food Science & Technology CrossRef
  18. null
    Punniyakoti Veeraveedu Thanikachalam et al, 2020 CrossRef
  19. Flavonoids in adipose tissue inflammation and atherosclerosis: one arrow, two targets
    Manal Muin Fardoun et al, 2020 CrossRef
  20. Epigallocatechin‑3‑gallate modulates long non‑coding RNA and mRNA expression profiles in lung cancer cells
    Dong‑Li Hu et al, 2019, Mol Med Report CrossRef
  21. The Impact of Dietary Supplementation of Whole Foods and Polyphenols on Atherosclerosis
    Abigail E. Cullen et al, 2020, Nutrients CrossRef
  22. Epigenetic mechanisms underlying the benefits of flavonoids in cardiovascular health and diseases: are long non-coding RNAs rising stars?
    Yang Jiang et al, 2021, Critical Reviews in Food Science and Nutrition CrossRef
  23. Green Tea and Coffee Consumption and All-Cause Mortality Among Persons With and Without Stroke or Myocardial Infarction
    Masayuki Teramoto et al, 2021, Stroke CrossRef
  24. Novel Therapeutical Approaches to Managing Atherosclerotic Risk
    Rosaria Vincenza Giglio et al, 2021, IJMS CrossRef
  25. Let-7a-5p regulated by lncRNA-MEG3 promotes functional differentiation to Schwann cells from adipose derived stem cells via directly inhibiting RBPJ-mediating Notch pathway
    Wei Wang et al, 2021, Apoptosis CrossRef
  26. Harnessing polyphenol power by targeting eNOS for vascular diseases
    Mamali Das et al, 2021, Critical Reviews in Food Science and Nutrition CrossRef
  27. The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial
    Ren Yoshitomi et al, 2021, Sci Rep CrossRef
  28. The proliferation and migration of atherosclerosis‐related HVSMCs were inhibited by downregulation of lncRNA XIST via regulation of the miR ‐761/ BMP9 axis
    Long Mo et al, 2021, The Kaohsiung Journal of Medical Sciences CrossRef
  29. null
    Md Jahangir Alam et al, 2022 CrossRef
  30. Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: novel insights into therapeutic effects beyond its antioxidant and anti-inflammatory properties
    Yonela Ntamo et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  31. Therapeutic Targeting Notch2 Protects Bone Micro-Vasculatures from Methotrexate Chemotherapy-Induced Adverse Effects in Rats
    Yaser Peymanfar et al, 2022, Cells CrossRef
  32. Agri-Food Waste from Apple, Pear, and Sugar Beet as a Source of Protective Bioactive Molecules for Endothelial Dysfunction and Its Major Complications
    Cristiana Caliceti et al, 2022, Antioxidants CrossRef
  33. The medicinal value of tea drinking in the management of COVID-19
    Jiaming Ge et al, 2023, Heliyon CrossRef
  34. (+)‐Catechin Attenuates Multiple Atherosclerosis‐Associated Processes In Vitro, Modulates Disease‐Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque Stability
    Yee‐Hung Chan et al, 2023, Molecular Nutrition Food Res CrossRef
  35. Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease
    Qian Yan et al, 2023, J Transl Med CrossRef
  36. Effects of Bioactive Components of Tea on Vascular Endothelial Dysfunction
    瑞 呼, 2023, ACM CrossRef
  37. Recent Updates on Epigenetic-Based Pharmacotherapy for Atherosclerosis
    Eko Fuji Ariyanto et al, 2024, DMSO CrossRef
  38. null
    Yanjun Yin et al, 2024 CrossRef
  39. Epigallocatechin-3-gallate inhibits osteogenic differentiation of vascular smooth muscle cells through the transcription factor JunB
    Tiantian Li et al, 2024, ABBS CrossRef
  40. Advances in the Anti-Atherosclerotic Mechanisms of Epigallocatechin Gallate
    Yihui Liu et al, 2024, Nutrients CrossRef
  41. Drug-Loaded Mesoporous Polydopamine Nanoparticles in Chitosan Hydrogels Enable Myocardial Infarction Repair through ROS Scavenging and Inhibition of Apoptosis
    Tianhu Wang et al, 2024, ACS Appl. Mater. Interfaces CrossRef